IP Library Granted Patent US 7,604,963
Granted Patent B2
US 7,604,963 · App. 10/565,750 · Granted Oct 20, 2009

Method for sequencing nucleic acid molecules

Assignee: Medical Biosystems Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,604,963
App. No.
10/565,750
Granted
Oct 20, 2009
Kind
B2
Abstract

The sequence of a target polynucleotide can be determined by: (i) contacting the target polynucleotide with a polymerase enzyme and one of the nucleotides A, T(U), G, and C under conditions suitable for the polymerase reaction to proceed; (ii) measuring the time taken for the polymerase to bind to and subsequently dissociate from the target polynucleotide, to thereby determine whether the polymerase has incorporated the nucleotide onto the target polynucleotide; (iii) optionally repeating steps (i) and (ii) with additional nucleotides, to thereby identify the sequence of the target polynucleotide.

Claims (24)

1. A method for identifying the sequence of a target polynucleotide, comprising:

(i) contacting the target polynucleotide with a polymerase enzyme and a nucleotide selected from the group consisting of A, T (U), G, and C, under conditions suitable for the polymerase reaction to proceed;

(ii) measuring the time taken for the polymerase to bind to and subsequently dissociate from the target polynucleotide, to thereby determine whether the polymerase has incorporated the nucleotide onto the target polynucleotide;

(iii) optionally repeating (i) and (ii) with additional nucleotides, to thereby identify the sequence of the target polynucleotide.

2. The method according to claim 1 , wherein (i) and (ii) are carried out with each of the different nucleotides in turn, until incorporation is detected.

3. The method according to claim 1 , wherein the target polynucleotide is immobilized on a support material.

4. The method according to claim 1 , wherein a plurality of target polynucleotides is immobilized on a support material.

5. The method according to claim 1 , wherein (ii) is carried out by measuring applied radiation.

6. The method according to claim 1 , wherein (ii) is carried out by measuring raman scattering.

7. The method according to claim 1 , wherein (ii) is carried out by applying a surface electromagnetic wave.

8. The method according to claim 7 , wherein the surface electromagnetic wave is a surface plasmon wave.

9. The method according to claim 1 , wherein detection is carried out by measurement of a surface electromagnetic wave.

10. The method according to claim 1 , wherein the polymerase comprises a detectable label attached thereto.

11. The method according to claim 10 , wherein the label is a fluorophore.

12. The method according to claim 10 , wherein the polymerase further comprises an energy donor label or an energy acceptor label, and wherein (ii) is carried out by measuring energy transfer between the fluorophore and the energy donor or acceptor.

13. A method for the identification of a mutation in a target polynucleotide, comprising:

(i) contacting the target polynucleotide with a polymerase enzyme and a nucleotide selected from the group consisting of A, T (U), G, and C, under conditions suitable for the polymerase reaction to proceed;

(ii) measuring the time taken for the polymerase to bind to and subsequently dissociate from the target polynucleotide, to thereby identify whether the polymerase has incorporated the nucleotide onto the target polynucleotide, and with reference to the native sequence of the target, determine whether a mutation exists.

14. The method according to claim 13 , wherein (i) and (ii) are carried out with each of the different nucleotides in turn, until incorporation is detected.

15. The method according to claim 13 , wherein a plurality of target polynucleotides is immobilized on a support material.

16. The method according to claim 13 , wherein (ii) is carried out by applying a surface electromagnetic wave.

17. The method according to claim 16 , wherein the surface electromagnetic wave is a surface plasmon wave.

18. The method according to claim 13 , wherein the polymerase comprises a detectable label attached thereto.

19. The method according to claim 18 , wherein the polymerase further comprises an energy donor label or an energy acceptor label, and wherein (ii) is carried out by measuring energy transfer between the fluorophore and the energy donor or acceptor.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MEDICAL BIOSYSTEMS LIMITED
To: REJUVIGEN LIMITED
Reel/Frame 024896/0283 →
CHANGE OF NAME Recorded Aug 27, 2010
From: REJUVIGEN LIMITED
To: MOBIOUS BIOSYSTEMS LIMITED
Reel/Frame 024896/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MOBIOUS BIO SYSTEMS LIMITED
To: GEN-PROBE INCORPORATED
Reel/Frame 024896/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2008
From: DENSHAM, DANIEL
To: MEDICAL BIOSYSTEMS LTD
Reel/Frame 021692/0764 →
Priority Claims (1)
GB 0317343.2 · Jul 24, 2003 · national
Continuity (1)
Related Publication 20080070236A1 · Mar 20, 2008